Skip to Content

TEVA 22 10 (Sucralfate 1 g)

Pill with imprint TEVA 22 10 is White, Capsule-shape and has been identified as Sucralfate 1 g. It is supplied by Teva Pharmaceuticals USA.

Sucralfate is used in the treatment of gerd; duodenal ulcer; hyperphosphatemia of renal failure; duodenal ulcer prophylaxis; stomach ulcer (and more), and belongs to the drug class miscellaneous GI agents. There is no proven risk in humans during pregnancy. Sucralfate 1 g is not a controlled substance under the Controlled Substances Act (CSA).

Images for TEVA 22 10

Sucralfate 1 g TEVA 22 10
Sucralfate 1 g TEVA 22 10 Front
Sucralfate 1 g TEVA 22 10 Back
Sucralfate 1 g TEVA 22 10
Sucralfate 1 g TEVA 22 10
Sucralfate 1 g TEVA 22 10

Sucralfate

Imprint:
TEVA 22 10
Strength:
1 g
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Miscellaneous GI agents
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide